The results also indicated that lidocaine inhibited EMT and metastasis potential of ovarian cancer cells, and NaV1.5 knockdown or blockage impaired the EMT and metastatic properties of ovarian cancer cells. Here, SCN5A is linked to ovarian carcinoma.